By Matt Grossman
Johnson & Johnson on Wednesday raised its guidance for adjusted earnings and for revenue growth in 2021.
The New Brunswick, N.J.-based pharmaceutical company said it now expects adjusted earnings of $9.60 to $9.70 a share this year. In April, it had forecast adjusted earnings of $9.42 to $9.57 a share.
The company said it now expects sales of $93.8 billion to $94.6 billion. In April, it had forecast sales of $90.6 billion to $91.6 billion.
The earnings and sales forecasts include estimates of J&J's Covid-19 vaccine operations.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
07-21-21 0658ET